Vertex Pharmaceuticals
VRTX
#180
Rank
NZ$195.67 B
Marketcap
NZ$763.19
Share price
-0.12%
Change (1 day)
-5.63%
Change (1 year)

Earnings for Vertex Pharmaceuticals (VRTX)

Earnings in 2025 (TTM): NZ$7.67 Billion

According to Vertex Pharmaceuticals's latest financial reports the company's current earnings are NZ$11.72 Billion. In 2024 the company made an earning of NZ$0.47 Billion a decrease over its 2023 earnings that were of NZ$7.60 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Vertex Pharmaceuticals from 1990 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) NZ$7.67 B1499.56%
2024 NZ$0.47 B-93.69%
2023 NZ$7.60 B3.19%
2022 NZ$7.36 B53.56%
2021 NZ$4.79 B-12.06%
2020 NZ$5.45 B118.45%
2019 NZ$2.49 B120.64%
2018 NZ$1.13 B1473.64%
2017 NZ$71.93 M197.6%
2016 NZ$24.17 M-102.97%
2015 -NZ$0.82 Billion-28.46%
2014 -NZ$1.14 Billion-51.5%
2013 -NZ$2.35 Billion-30584.68%
2012 NZ$7.69 M-95.47%
2011 NZ$0.16 B
2009 -NZ$1.02 Billion
2007 -NZ$0.71 Billion83.1%
2006 -NZ$0.39 Billion59.02%
2005 -NZ$0.25 Billion3.28%
2004 -NZ$0.24 Billion-38.16%
2003 -NZ$0.39 Billion
2000 -NZ$65.38 Million-20.38%
1999 -NZ$82.11 Million31.62%
1998 -NZ$62.39 Million91.05%
1997 -NZ$32.66 Million-36.24%
1996 -NZ$51.22 Million12.45%
1995 -NZ$45.55 Million27.4%
1994 -NZ$35.75 Million-1833.33%
1993 NZ$2.06 M-112.12%
1992 -NZ$17.02 Million175%
1991 -NZ$6.19 Million-12.2%
1990 -NZ$7.05 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Gilead Sciences
GILD
NZ$16.98 B 121.58%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
NZ$2.85 B-62.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$39.68 B 417.54%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$13.80 B 80.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
NZ$55.67 B 626.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Enanta Pharmaceuticals
ENTA
-NZ$0.15 Billion-101.93%๐Ÿ‡บ๐Ÿ‡ธ USA